Related Experiment Videos
Total coronary occlusion: a different animal?
1Cardiology Center, University Hospital, Geneva, Switzerland.
Insights
Chronic total coronary occlusions (CTO) mimic stenosis but lack infarction risk. Angioplasty for CTO has a 65% success rate, but high recurrence rates limit clinical benefit, favoring bypass surgery.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Biology
Background:
- Chronic total coronary occlusions (CTO) present clinically similar to severe stenoses but do not pose an immediate risk of myocardial infarction.
- Angioplasty for CTO involves balancing technical challenges and risks against potential patient benefit and myocardial viability.
- Understanding CTO characteristics is crucial for guiding treatment decisions and improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and limitations of angioplasty for treating chronic total coronary occlusions.
- To identify predictors of success and recurrence in CTO angioplasty.
- To compare the clinical yield of CTO angioplasty with that of coronary stenoses.
Main Methods:
- Retrospective analysis of angioplasty procedures for chronic total coronary occlusions.
- Assessment of primary success rates, complication profiles, and recurrence rates (reocclusion and restenosis).
- Evaluation of factors influencing procedural success, including occlusion duration and length.
Main Results:
- Primary success rate for CTO angioplasty is approximately 65%, with rare complications.
- Abrupt vessel reclosure, though common, is typically harmless.
- Recurrence rates average 68% within 6 months, driven by collateral competition and suboptimal results.
- Occlusion duration and segment length are key predictors of success.
Conclusions:
- Despite technical advancements, the clinical yield of CTO angioplasty remains limited compared to stenoses.
- High recurrence rates necessitate cost-effective and low-risk approaches, favoring conventional balloon angioplasty.
- CTO angioplasty techniques can inform improvements for non-total coronary lesions, though CTOs often warrant bypass surgery.
Abstract:
Provided collateralization is adequate, a chronic total coronary occlusion clinically imitates a 90% stenosis but is exempt from the risk of myocardial infarction. For angioplasty of vessels with chronic total coronary occlusion, technical difficulties and clinical risks are balanced against projected subjective benefit and amount of viable myocardium concerned. The primary success rate is approximately 65% and complications are rare because abrupt vessel reclosure may be common but is harmless. New Q wave infarction in that context has not been reported. The duration of occlusion is the most important predictor of success. The length of the occluded segment is also important. Recurrence averages 68% (21% reocclusion and 47% restenosis) and happens typically within 6 months. The high recurrence rate is due to competitive pressure exerted by collateral vessels and an often suboptimal local result. Even if the primary success rate of angioplasty in vessels with chronic total coronary occlusion can be improved by advanced technology and skill, the clinical yield will remain low compared with that of angioplasty of stenoses. Because low yield procedures must be low risk and low cost, there are definite limits to how sophisticated, risky and expensive new techniques can become. Derivatives of conventional balloon systems are likely to remain the equipment of first choice, perhaps complemented by mechanical drills. Although chronic total coronary occlusions are no clinical menace in contrast to stenoses, they frequently deserve revascularization and are the reason to select bypass surgery over angioplasty. These factors justify endeavors to improve recanalization techniques that help to refine coronary angioplasty of nontotal lesions, because total occlusion, albeit a different animal, is of the same species.